The oncogene bcl-2 encodes a 26-kD protein localized to intracellular
membranes, including the ER, mitochondria, and perinuclear membrane, b
ut its mechanism of action is unknown. We have been investigating the
hypothesis that Bcl-2 regulates the movement of calcium ions (Ca2+) th
rough the ER membrane. Earlier findings in this laboratory indicated t
hat Bcl-2 reduces Ca2+ efflux from the ER lumen in WEHI7.2 lymphoma ce
lls treated with the Ca2+-ATPase inhibitor thapsigargin (TG) but does
not prevent capacitative entry of extracellular calcium. In this repor
t, we show that sustained elevation of cytosolic Ca2+ due to capacitat
ive entry is not required for induction of apoptosis by TG, suggesting
that ER calcium pool depletion may trigger apoptosis. Bcl-2 overexpre
ssion maintains Ca2+ uptake in the ER of TG-treated cells and prevents
a TG-imposed delay in intralumenal processing of the endogenous glyco
protein cathepsin D. Also, Bcl-2 overexpression preserves the ER Ca2pool in untreated cells when extracellular Ca2+ is low. However, low e
xtracellular Ca2+ reduces the antiapoptotic action of Bcl-2, suggestin
g that cytosolic Ca2+ elevation due to capacitative entry may be requi
red for optimal ER pool filling and apoptosis inhibition by Bcl-2. In
summary, the findings suggest that Bcl-2 maintains Ca2+ homeostasis wi
thin the ER, thereby inhibiting apoptosis induction by TG.